Portfolio
Discover our digital portfolio
Explore digital healthcare solutions and use cases from navify® and our third-party collaborators that can help your organization to deliver more operational, financial, and clinical value.
Algorithms: 6
navify® Algorithms, LGI-Flag
LGI-Flag is a software system that performs algorithm‐based analysis of demographic information and lab test results and provides personal scores to indicate individuals with higher probability of harboring colorectal cancer (CRC) compared to the general population.¹
navify® Algorithms, Chest Pain Triage algorithm
Transform your emergency department with Chest Pain Triage algorithm: aiding physicians in the diagnosis and risk stratification of adult patients with suspected acute coronary syndrome (ACS), using high-sensitive troponin* and evidence-based recommendations, adhering to European Society of Cardiology (ESC) guidelines.1
navify® Algorithms, GAAD
GAAD test to aid in the diagnosis of early and all stage hepatocellular carcinoma (HCC).¹
navify® Algorithms, Kidney KFRE Algorithm
Kidney KFRE Algorithm is a risk score predicting the likelihood of an individual patient to reach end-stage kidney disease within 2 and 5 years. It is applied to diagnosed patients with chronic kidney disease (CKD) in stages G3 to G5.¹
navify® Algorithms, Kidney Klinrisk Algorithm
Kidney Klinrisk Algorithm is a semi-quantitative in vitro diagnostic device intended as an aid in assessing the risk for progression of an individual patient to suffer significant decline in kidney function and/or to reach end stage kidney disease within a period of up to 5 years. It is intended for adult CKD patients in stages G1 to G4, and to diabetic and/or hypertensive patients that are at risk for CKD.
navify® Algorithms, FIB-4 Index and ADAPT by Evidencio, LiverPRO by Evido (coming soon)
Clinical algorithms to support MASLD assessment: FIB-4 Index helps triage advanced fibrosis likelihood¹, followed by ADAPT which helps assess fibrosis severity.²
Coming soon: A closer look into navify Algorithms, LiverPRO (by Evido)
- Not every digital product is available in all markets. The use of any third-party app is subject to a separate license agreement with the respective third-party app developer. Roche gives no warranties (express or implied) with regard to any third-party app. Third-party apps might not be available in your country. This website and its content may be accessible worldwide, Roche assumes no liability with regard to the access to the information, which may not be compatible with legislations or regulations in force in your country.